文献速递前列腺癌

前列腺癌主动监测中失访风险分析

Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer.
PubMed 文献 · Eur Urol · 2018-08-31

基于MUSIC前瞻性注册研究,2011-2017年44家泌尿外科 practice 中接受主动监测的前列腺癌患者,中位监测32个月,2年失访无事件概率为90%(95%CI=89-92%)。非裔美国种族和Charlson合并症指数≥1独立增加失访风险,各practice间2年无失访生存率存在变异但未达统计学显著(p=0.076)。

要点

  • 2年失访无事件概率约90%,即约10%患者失访。
  • 非裔美国种族(HR=2.77)和合并症指数≥1(HR=1.55)增加失访风险。
  • 各practice间2年无失访生存率变异大但未达统计学显著(p=0.076)。

核心结论

  • 主动监测患者中约10%在2年内失访,非裔美国种族和合并症负担是独立危险因素。

研究设计与样本

  • 基于MUSIC前瞻性注册研究,纳入2011-2017年44家学术和社区泌尿外科practice中接受主动监测的前列腺癌患者,中位监测32个月。

主要发现

  • 2年失访无事件概率为90%(95%CI=89-92%)。
  • 非裔美国种族失访风险HR=2.77(95%CI=1.81-4.24)。
  • Charlson合并症指数≥1失访风险HR=1.55(95%CI=1.08-2.23)。
  • 各practice间2年无失访生存率从52%(95%CI=21-100%)到99%(95%CI=97-100%),中位96%(IQR 94-98%),p=0.076。

临床怎么用

  • 泌尿外科practice应建立系统识别失访风险高的患者,尤其是非裔美国人和合并症较多者。
  • 需改善主动监测的长期随访质量以减少失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Active surveillance (AS) has emerged as the preferred management strategy for many men with prostate cancer (PC); however, insufficient longitudinal monitoring may increase the risk of poor outcomes. We sought to determine rates of patients becoming lost to follow-up (LTFU) and associated risk factors in a large AS cohort. The Michigan Urologic Surgery Improvement Collaborative (MUSIC) maintains a prospective registry of PC patients from 44 academic and community urology practices. Over a 6-yr period (2011-2017), we identified patients managed with AS. LTFU was defined as any 18-mo period where no pertinent surveillance testing was entered in the registry. With a median surveillance period of 32 mo, the estimated 2-yr LTFU-free probability calculated by Kaplan-Meier method was 90% (95% confidence interval [CI]=89-92%). Both African American race (hazard ratio [HR]: 2.77, 95% CI=1.81-4.24) and Charlson comorbidity index ≥1 (HR: 1.55, 95% CI=1.08-2.23) were independently associated with increased risk of LTFU. There was variability in rates of estimated 2-yr LTFU-free survival across MUSIC practices, ranging from 52% (95% CI=21-100%) to 99% (95% CI=97-100%), with a median of 96% (interquartile range: 94-98%), although this did not reach statistical significance (p=0.076). These data reveal opportunities for urology practices to identify systems to reduce rates of LTFU and improve the long-term safety of AS. PATIENT SUMMARY: With a median observation period of 32 mo, an estimated 10% of patients will be lost to follow-up at the 2 yr time point while on AS. African American men and generally unhealthy patients were at increased risk, and there was variability from one urology practice to another. There is ample opportunity to improve the quality of the performance of AS.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Ginsburg KB, Auffenberg GB, Qi J, et al. Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer. Eur Urol. 2018. PMID: 30177290. doi:10.1016/j.eururo.2018.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。